FORTIS Fortis Healthcare Q4 FY26 results (Jan–Mar 2026) and concall
Fortis Healthcare reported a strong Q4 and full-year FY26 performance, driven by robust revenue growth and significant EBITDA margin expansion across both hospital and diagnostic segments. The company continued its strategic capacity expansion through brownfield and inorganic routes, adding 800 beds. While occupancy saw a slight dip due to specific factors, management expressed confidence in future growth and margin improvement, backed by planned capex and potential equity infusion from IHH.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q4 FY26: revenue up 18.8%, net profit up 159.5% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|
| Revenue | 357 | 367 | 388 | 433 | 456 +28% | 443 +21% | 461 +19% |
| EBITDA | 60 | 67 | 71 | 88 | 100 +67% | 99 +48% | 110 +55% |
| Net profit | 40 | 40 | -42 | 52 | 125 +213% | 28 −30% | 25 +160% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
